Dr. May on Olaratumab Activity in Pediatric Bone and Soft Tissue Sarcoma
4 vistas
• 07/18/23
0
0
Empotrar
administrator
Suscriptores
Caitlin May, PhD, postdoctoral research fellowship at Eli Lilly and Company, discusses olaratumab's (Lartruvo) demonstrating anti-tumor activity in models of pediatric bone and soft-tissue sarcoma.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios